Concepedia

Publication | Closed Access

Cerivastatin, genetic variants, and the risk of rhabdomyolysis

DOI

103

Citations

32

References

2011

Year

Kristin D. Marciante, Jon Peter Durda, Susan R. Heckbert, Thomas Lumley, Barbara McKnight, Rheem A. Totah, Bani Tamraz, Deanna L. Kroetz, Hisayo Fukushima, Rüdiger Kaspera,
Pharmacogenetics and Genomics

Abstract

We identified modest genetic risk factors for an extreme response to cerivastatin. Disabling genetic variants in the candidate genes were not responsible for the bimodal response to cerivastatin.

References

YearCitations

Page 1